Bicara Therapeutics BCAX Effective Income Tax Rate Reconciliation, Percent

Effective Income Tax Rate Reconciliation, Percent at other companies

Century CommunitiesCCS

26.3%+1.0pp

HTF

Heartflow, Inc. Common StockHTFL

0%—

PopularBPOP

16%-4.2pp

Evolution Metals & Technologies Corp. EMAT

0%0.0pp

BeldenBDC

18.7%+2.4pp

ePlusPLUS

28.4%+0.4pp

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's effective income tax rate reconciliation, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's effective income tax rate reconciliation, percent?: Bicara Therapeutics (BCAX) reported effective income tax rate reconciliation, percent of -$0 in Q4 2025.